Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fibrin glue + hemostatic gauze is a combination product developed by Nanyue Bio, consisting of a plasma-derived biologic (fibrin glue) and a medical device (hemostatic gauze). It is designed for topical application to achieve surgical hemostasis and facilitate wound healing. The fibrin glue component typically contains fibrinogen and thrombin, which mimic the final stage of the natural coagulation cascade by forming a stable fibrin clot upon contact. The hemostatic gauze serves as a mechanical matrix that provides structural support for the clot and physical blockage of the bleeding site. This dual-action approach combines biochemical and mechanical hemostasis to manage bleeding during surgical procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fibrin glue + hemostatic gauze.